Toru Miyoshi Selected Research

Toru Miyoshi Research Topics

Disease

16	Myocardial Infarction 05/2022 - 10/2004
15	Coronary Artery Disease (Coronary Atherosclerosis) 05/2022 - 03/2010
15	Heart Failure 03/2022 - 03/2011
15	Atherosclerosis 01/2022 - 07/2006
10	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 03/2011
8	Inflammation (Inflammations) 06/2022 - 01/2008
8	Hypertension (High Blood Pressure) 11/2021 - 01/2010
8	Stable Angina 02/2021 - 03/2010
7	Acute Coronary Syndrome 01/2022 - 01/2014
7	Atrial Fibrillation 11/2021 - 07/2009
7	Spasm (Spasms) 03/2016 - 01/2014
6	Pathologic Constriction (Stenosis) 12/2022 - 09/2008
6	Insulin Resistance 03/2022 - 07/2010
6	Hypertriglyceridemia 01/2022 - 08/2011
6	Ischemia 01/2022 - 10/2005
6	Hypertrophy 05/2019 - 12/2010
6	Infarction (Infarctions) 01/2016 - 10/2004
5	Type 2 Diabetes Mellitus (MODY) 01/2022 - 07/2014
5	Fibrosis (Cirrhosis) 01/2021 - 12/2010
5	Body Weight (Weight, Body) 05/2019 - 11/2008
4	Diabetes Mellitus 05/2022 - 06/2018
4	Chest Pain (Chest Pains) 02/2022 - 02/2016
4	Death (Near-Death Experience) 01/2022 - 03/2011
4	Hypercholesterolemia 01/2022 - 06/2015
4	Thrombosis (Thrombus) 06/2019 - 05/2016
4	Chronic Renal Insufficiency 01/2019 - 12/2017
4	Hyperlipidemias (Hyperlipidemia) 04/2016 - 08/2011
4	Neoplasms (Cancer) 12/2015 - 10/2004
3	Acute Kidney Injury (Acute Renal Failure) 02/2021 - 01/2015
3	Pulmonary Arterial Hypertension 01/2021 - 04/2017
3	Unstable Angina 09/2019 - 01/2014
3	Cardiomegaly (Heart Hypertrophy) 05/2019 - 02/2014
3	Hypoxia (Hypoxemia) 04/2017 - 06/2009
3	Atherosclerotic Plaque (Atheroma) 03/2014 - 03/2010
2	Non-alcoholic Fatty Liver Disease 05/2022 - 01/2021
2	Myocarditis (Carditis) 02/2022 - 01/2021
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 04/2014
2	ST Elevation Myocardial Infarction 06/2021 - 01/2015
2	Hyperemia 12/2020 - 10/2017
2	Proteinuria 01/2019 - 01/2010
2	Essential Hypertension 01/2017 - 07/2011
2	Coronary Disease (Coronary Heart Disease) 04/2016 - 08/2011

Drug/Important Bio-Agent (IBA)

12	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2022 - 08/2011
8	Eicosapentaenoic AcidIBA 06/2018 - 03/2011
7	Phenobarbital (Luminal)FDA Link 12/2022 - 01/2015
6	oxidized low density lipoproteinIBA 05/2022 - 11/2006
6	LipidsIBA 01/2021 - 08/2011
6	LDL CholesterolIBA 12/2020 - 07/2011
6	Fatty Acid-Binding ProteinsIBA 10/2017 - 07/2010
6	Acetylcholine (Acetylcholine Chloride)FDA Link 03/2016 - 01/2015
5	Biomarkers (Surrogate Marker)IBA 06/2022 - 07/2013
5	Messenger RNA (mRNA)IBA 02/2022 - 10/2004
5	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 07/2009
5	voglibose (Basen)IBA 01/2022 - 07/2014
5	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2017 - 11/2008
5	olmesartanIBA 03/2014 - 03/2010
4	Sodium-Glucose Transport ProteinsIBA 03/2022 - 01/2019
4	omega-Chloroacetophenone (Mace)IBA 01/2022 - 03/2011
4	Nicorandil (SG 75)IBA 02/2021 - 06/2017
4	LDL Lipoproteins (beta Lipoproteins)IBA 01/2020 - 10/2014
4	Angiotensin Receptor AntagonistsIBA 03/2019 - 03/2014
4	C-Reactive ProteinIBA 01/2018 - 01/2005
4	Ezetimibe (Zetia)FDA Link 06/2015 - 08/2011
4	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 11/2008 - 11/2006
3	CalciumIBA 06/2022 - 01/2021
3	Sodium-Glucose Transporter 2 InhibitorsIBA 03/2022 - 01/2019
3	1,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitolIBA 01/2022 - 01/2019
3	Bisoprolol (Concor)FDA LinkGeneric 11/2021 - 08/2011
3	MonocrotalineIBA 01/2021 - 04/2017
3	Pharmaceutical PreparationsIBA 01/2020 - 04/2017
3	pitavastatin (itavastatin)FDA Link 01/2020 - 01/2018
3	Glycoside Hydrolase InhibitorsIBA 01/2019 - 07/2014
3	Cystatin CIBA 09/2018 - 07/2013
3	Ergonovine (Ergometrine)IBA 03/2016 - 09/2015
3	Triglycerides (Triacylglycerol)IBA 10/2014 - 07/2011
3	Proteins (Proteins, Gene)FDA Link 12/2010 - 01/2008
3	Apolipoproteins E (ApoE)IBA 05/2009 - 01/2008
3	ApolipoproteinsIBA 05/2009 - 07/2006
2	Malondialdehyde (Propanedial)IBA 05/2022 - 09/2019
2	Lipoprotein(a)IBA 05/2022 - 06/2018
2	evolocumabIBA 05/2022 - 12/2020
2	Glucose (Dextrose)FDA LinkGeneric 03/2022 - 01/2022
2	Neprilysin (Neutral Endopeptidase)IBA 01/2022 - 01/2019
2	DiureticsIBA 01/2022 - 01/2017
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2022 - 01/2019
2	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022 - 01/2019
2	CreatinineIBA 02/2021 - 12/2020
2	Docosahexaenoic AcidsIBA 01/2021 - 01/2021
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2021 - 01/2021
2	CollagenIBA 01/2021 - 09/2006
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 05/2019
2	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 04/2020
2	AlbuminsIBA 12/2020 - 01/2010
2	Therapeutic UsesIBA 04/2020 - 01/2019
2	Epoprostenol (Prostacyclin)FDA LinkGeneric 11/2019 - 04/2017
2	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2019 - 02/2014

Therapy/Procedure

21	Percutaneous Coronary Intervention 05/2022 - 03/2009
18	Therapeutics 01/2022 - 06/2005
5	Stents 01/2019 - 05/2016
3	Catheter Ablation 12/2020 - 09/2008